Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZARGA as Replacement Therapy for COMBIGAN in Glaucoma or Ocular Hypertension
NCT01518244Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Dec 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of brinzolamide in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Mean Change in Intraocular Pressure (IOP) From Baseline (Prior Therapy) at 8 weeks. Started Dec 2011; status: completed.
02
Drugs
brinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01518244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518244.